1 June 2016 in The Journal of Pediatrics
21 March 2022 in Hormone Research in Paediatrics
Introduction: Turner syndrome (TS) results from a complete or partial loss of the X chromosome and affects 25–50 per 100,000 females. These individuals have characteristic neurocognitive and psychological profiles with an increased lifetime prevalence of mood disorders, such as depression and anxiety. Consensus guidelines recommend the use of psychometrically robust tools to screen for these conditions [Eur J Endocrinol. 2017;177(3):G1–G70 and Gynecol Endocrinol. 2004;19(6):313–9]. We propose a sustainable and informative approach to routine anxiety screening in individuals with TS and describe the prevalence of anxiety, genotype-phenotype associations, and impact of comorbidities on anxiety. Methods: We pilot the use of a self-administered version of the validated Pediatric, Parent Proxy, and Adult Patient-Reported Outcomes Measurement Information System (PROMIS®) Anxiety tool during routine visits to the Cincinnati Children’s Hospital Medical Center (CCHMC) TS clinic from October 2019 to March 2020. Results: Ninety-two eligible TS females, ages 8–62 years, received the PROMIS® Anxiety measure. Elevated anxiety scores, ≥1 standard deviation above the T-score mean, were present in 65% of patients (38% mild, 19% moderate, and 8% severe). Results were discussed during the clinic visit, and referral for further evaluation and treatment was offered. There was no apparent genotype-phenotype association among females with anxiety; however, there appeared to be elevated anxiety symptoms (T-score >60) in those with hearing deficits and also in individuals with three or more medical comorbidities. Of the 55% of patients who filled out the acceptability survey, 88% found the process helpful and ∼50% felt that screening should be performed at least every 6 months. Conclusion: Our study demonstrated a high prevalence of anxiety symptoms within a cohort of 92 females with TS. In alignment with current guidelines, these findings indicate the importance of routine neuropsychological assessments for timely recognition and subsequent management of anxiety, especially as milder presentations may otherwise go unnoticed. We have shown that screening tools, such as the PROMIS® Anxiety measure, can be easily utilized by nonmental health care providers (i.e., endocrinologists) who may see TS patients more frequently and be able to initiate impactful discussions surrounding mental health and further referral to subspecialists for expert management.
20 June 2024 in The Clinical Neuropsychologist
Objective: Despite varying opinions, little research has examined how to best write pediatric neuropsychology reports. Method: This study gathered input from 230 parents on how text difficulty (reading level) and visual emphasis (bullets, underline, italics) affect report readability and utility. We focused on the most-read report section: summary/impressions. Each parent rated the readability and usefulness of a generic summary/impressions section written in four different styles. The four styles crossed text difficulty (high school-vs-collegiate) with use of visual emphasis (absent-vs-present). Results: Parents found versions with easier text to be more clearly written, easier to follow, and easier to find information (p<.001). Parents rated those with harder text to be overly detailed, complex, hard to understand, and hard to read (p<.001). Visual emphasis made it easier to find key information and the text easier to follow and understand - but primarily for versions that were written in difficult text (interaction p≤.026). After rating all four styles, parents picked their preference. They most often picked versions written in easier text with visual emphasis (p<.001). Conclusions: Findings support writing styles that use easier text difficulty and visual emphasis.
27 August 2026 in Pediatric Blood & Cancer
Background: Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive ribosomopathy characterized by bone marrow failure and multisystem involvement, with emerging evidence of associated neurocognitive impairment. Methods: We conducted a retrospective study of 240 individuals with biallelic Shwachman–Bodian–Diamond syndrome (SBDS) mutations enrolled in the North American SDS Registry to characterize neuropsychological, psychiatric, educational, functional, and neuroimaging outcomes. Medical records were reviewed, and neuropsychological scores were converted to z ‐scores and categorized as weakness (1.0–1.4 SD below the mean) or impairment (≥1.5 SD below the mean). Results: Fourteen individuals completed formal neuropsychological evaluations (mean age 10.66 years). Median full‐scale IQ z ‐score was −0.47 (SD 1.28), with 41.7% demonstrating intellectual weakness or impairment. Adaptive functioning showed the highest rate of impairment (100%). Executive functioning, visual‐motor integration, spelling, and mathematics were commonly affected, whereas immediate verbal learning was preserved. Longitudinal data from five patients demonstrated stable overall intellectual and generally stable adaptive functioning over time, with variability in higher order cognitive and psychosocial domains. Educational support needs were substantial: 73.9% required specialized educational programs and 51.9% had an individualized education program. Neurodevelopmental disorders were reported in 49% of those with available data, most commonly attention‐deficit/hyperactivity disorder, and 23.5% had mental health diagnoses, most frequently anxiety. Neuroimaging was abnormal in a subset, most often reflecting structural brain differences. Conclusions: These findings indicate that individuals with SDS are at elevated risk for neurocognitive weaknesses and significant educational needs. Although global intellectual functioning appears relatively stable over time, domain‐specific vulnerabilities and adaptive impairment warrant routine neuropsychological monitoring and early intervention.